Galderma and Mentor Worldwide LLC, are joining forces to increase awareness and provide a broader range of offerings to healthcare providers and patients seeking aesthetic injectable treatments and breast enhancement.

Data shows up to 33% of women who had injectable treatments also had breast augmentation, according to 2014 research by Bain & Company.

The new collaboration will include Galderma’s aesthetic brands, including the Restylane® family of fillers, Dysport®* (abobotulinumtoxinA) 300 units for Injection and Sculptra® Aesthetic, along with the U.S.-made MENTOR® MemoryShape® and MENTOR® MemoryGel® Breast Implants portfolio, for the U.S. aesthetics (non-reimbursed) market.

The two companies will look for opportunities to leverage market growth strategies to benefit both healthcare providers and consumers. For Galderma, this will include ASPIRE Galderma Rewards loyalty program.